These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. Jacobson JM; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Wu AW; Hooton TM; Sha BE; Shikuma CM; MacPhail LA; Simpson DM; Trapnell CB; Basgoz N J Infect Dis; 1999 Jul; 180(1):61-7. PubMed ID: 10353862 [TBL] [Abstract][Full Text] [Related]
23. Alternative therapies for major aphthous ulcers in AIDS patients. Glick M; Muzyka BC J Am Dent Assoc; 1992 Jul; 123(7):61-5. PubMed ID: 1619168 [No Abstract] [Full Text] [Related]
24. Aphthous vaginal ulceration in two women with acquired immunodeficiency syndrome. Schuman P; Christensen C; Sobel JD Am J Obstet Gynecol; 1996 May; 174(5):1660-3. PubMed ID: 9065154 [TBL] [Abstract][Full Text] [Related]
25. Thalidomide: treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virus. Ghigliotti G; Repetto T; Farris A; Roy MT; De Marchi R J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):271-2. PubMed ID: 8432932 [No Abstract] [Full Text] [Related]
27. [Aphthosis major treated with thalidomide in a patient with AIDS]. Allegue F; Sarriá Cepeda C; García Rodríguez M Enferm Infecc Microbiol Clin; 1991 Feb; 9(2):133-4. PubMed ID: 1854850 [No Abstract] [Full Text] [Related]
33. Oral ulceration in HIV infection: investigation and pathogenesis. MacPhail LA; Greenspan JS Oral Dis; 1997 May; 3 Suppl 1():S190-3. PubMed ID: 9456687 [TBL] [Abstract][Full Text] [Related]
34. Recurrent aphthous ulcerative disease: presentation and management. Vucicevic Boras V; Savage NW Aust Dent J; 2007 Mar; 52(1):10-5; quiz 73. PubMed ID: 17500158 [TBL] [Abstract][Full Text] [Related]
35. The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration. Nolan A; Baillie C; Badminton J; Rudralingham M; Seymour RA J Oral Pathol Med; 2006 Sep; 35(8):461-5. PubMed ID: 16918596 [TBL] [Abstract][Full Text] [Related]
36. Thalidomide for the treatment of acquired immunodeficiency syndrome-associated refractory oral ulcers. Diz Dios P; Sopeña B; Cameselle J; Butrón M; Crespo M; Ocampo A Arch Otolaryngol Head Neck Surg; 2000 Jan; 126(1):89-92. PubMed ID: 10628719 [TBL] [Abstract][Full Text] [Related]
37. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS. Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925 [TBL] [Abstract][Full Text] [Related]
38. Major aphthous-like ulcers in patients with AIDS. Phelan JA; Eisig S; Freedman PD; Newsome N; Klein RS Oral Surg Oral Med Oral Pathol; 1991 Jan; 71(1):68-72. PubMed ID: 1994326 [TBL] [Abstract][Full Text] [Related]
39. Idiopathic esophageal ulceration in acquired immunodeficiency syndrome: successful treatment with misoprostol and viscous lidocaine. Adeoti AG; Vega KJ; Dajani EZ; Trotman BW; Kloser PC Am J Gastroenterol; 1998 Nov; 93(11):2069-74. PubMed ID: 9820375 [TBL] [Abstract][Full Text] [Related]
40. A clinical trial of prostaglandin E2 in recurrent aphthous ulceration. Taylor LJ; Walker DM; Bagg J Br Dent J; 1993 Aug; 175(4):125-9. PubMed ID: 8357678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]